343 related articles for article (PubMed ID: 33112200)
61. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
62. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
Kralik SF; Singhal KK; Frank MS; Ladd LM
AJR Am J Roentgenol; 2018 Nov; 211(5):1063-1067. PubMed ID: 30106613
[TBL] [Abstract][Full Text] [Related]
64. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Zivadinov R; Bergsland N; Hagemeier J; Ramasamy DP; Dwyer MG; Schweser F; Kolb C; Weinstock-Guttman B; Hojnacki D
Neurology; 2019 Aug; 93(6):e611-e623. PubMed ID: 31285398
[TBL] [Abstract][Full Text] [Related]
65. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
66. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Splendiani A; Corridore A; Torlone S; Martino M; Barile A; Di Cesare E; Masciocchi C
Insights Imaging; 2019 Sep; 10(1):82. PubMed ID: 31482392
[TBL] [Abstract][Full Text] [Related]
67. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
68. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
69. Intrathecal Contrast-Enhanced Magnetic Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?
Öner AY; Barutcu B; Aykol Ş; Tali ET
Invest Radiol; 2017 Apr; 52(4):195-197. PubMed ID: 27755154
[TBL] [Abstract][Full Text] [Related]
70. Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.
Kühn I; Maschke H; Großmann A; Hauenstein K; Weber MA; Zettl UK; Storch A; Walter U
Neurol Sci; 2022 Apr; 43(4):2631-2639. PubMed ID: 34735650
[TBL] [Abstract][Full Text] [Related]
71. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
Koiso T; Yamamoto M; Watanabe S; Barfod BE
Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
[TBL] [Abstract][Full Text] [Related]
72. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
[TBL] [Abstract][Full Text] [Related]
73. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
[TBL] [Abstract][Full Text] [Related]
75. Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance.
Meloni A; Montanaro D; De Marchi D; Resta M; Keilberg P; Pistoia L; Positano V; Spasiano A; Casini T; De Bari CC; De Cori S; Pepe A
Clin Neuroradiol; 2021 Jun; 31(2):347-355. PubMed ID: 32185401
[TBL] [Abstract][Full Text] [Related]
76. Measurements of signal intensity of globus pallidus and dentate nucleus suggest different deposition characteristics of macrocyclic GBCAs in children.
Olchowy C; Maciąg EJ; Sanchez-Montanez A; Olchowy A; Delgado I; Vazquez E
PLoS One; 2018; 13(12):e0208589. PubMed ID: 30586415
[TBL] [Abstract][Full Text] [Related]
77. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
Young JR; Pope WB; Bobinski M
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
[TBL] [Abstract][Full Text] [Related]
78. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
79. Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients.
Hojreh A; Mulabdic A; Furtner J; Krall C; Pogledic I; Peyrl A; Baltzer PAT
Eur J Radiol; 2023 Dec; 169():111179. PubMed ID: 37949021
[TBL] [Abstract][Full Text] [Related]
80. MRI Brain Signal Intensity and Relaxation Times in Individuals with Prior Exposure to Gadobutrol.
Saake M; Schmidle A; Kopp M; Hanspach J; Hepp T; Laun FB; Nagel AM; Dörfler A; Uder M; Bäuerle T
Radiology; 2019 Mar; 290(3):659-668. PubMed ID: 30599101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
